Optimizing Pharmaceutical Manufacturing Performance with Virtual Commissioning

Commissioning and qualification (C&Q) are terms and processes synonymous with the Good Manufacturing Practices (GMP) of biotechnology and pharmaceutical therapies, but the challenges associated with time consuming and costly traditional C&Q process are not to be understated. Virtual commissioning provides Life Sciences companies with the agility and ability to react quickly without compromising quality - 2 of the keys to success in the changing dynamics and challenges of the pharmaceutical manufacturing landscape.

Integration and qualification tests done manually, late in the engineering process and on site, using the actual physical plant or line that needs to be controlled, delays the start of production.  With a virtual twin of the manufacturing line, the commissioning, integration and qualification processes can be simulated prior to construction of the pharma manufacturing line, bringing the plant online sooner and getting medicines to patients faster.

Claire BIOT
Vice President, Life Sciences & Healthcare Industry - Dassault Systèmes

The Challenges

The challenges associated with GMP commissioning and qualification are many but the most notable of them is completing this mandatory activity as effectively and quickly as possible. Life Sciences companies strive to quickly deliver flexible, GMP compliant lines with the required level of performance, to fully trained operators - without stopping production. But, relying on manufacturing equipment, often from third parties, with little visibility and discovering problems late in the process all hinder their ability to quickly introduce new equipment lines and deliver more personalized batches of new therapies, more often.

See infographics
Virtual Commissioning Process > mobile infographic > Dassault Systèmes®
See infographics
Virtual Commissioning Process > Desktop infographic > Dassault Systèmes®
Virtual Commissioning Process

The Solution

With Dassault Systèmes Line Virtual Commissioning experience, you can simulate and create a virtual twin of your entire system, which can be tested and validated even before being implemented in the real physical plant, thus, saving you time and money. With Line Virtual Commissioning you can:

  • Get an overview of the system as soon as possible: allowing the ability to modify the process and the physical plant in the virtual world before implementation
  • Create and manage dedicated component libraries for pharmaceutical processes
  • Test and validate the control system of production lines and equipment in automatic and manual mode, including  virtual plant behavior simulations
  • Support high level test process, including generation of GMP compliance documentation for the development of the simulation model
  • Iterate quickly to find the best alternative & reuse the simulation model as Operator Training Systems for simulation of stress situations

 

 

The Benefits

40% Reduction of commissioning time  > Circle > Dassault Systèmes®

40% Reduction of commissioning time

15% Reduction of total time-to-market  > Circle > Dassault Systèmes®

15% Reduction of total time-to-market

80% Deviation reduction - Re-engineering  > Circle > Dassault Systèmes®

80% Deviation reduction - Re-engineering

40% Risk reduction of test batch loss > Circle > Dassault Systèmes®

40% Risk reduction of test batch loss

25% FTE reduction > Circle > Dassault Systèmes®

25% FTE reduction

We do it for you

The transition to virtual commissioning may be challenging for companies. That is why Dassault Systèmes can do it for you. Our experts can build a virtual twin of your facility and equipment line from 3D scans and 2D drawings or pictures. Results can be directly applied within your projects to secure benefits and value in a short timeframe.

Explore our Industry Solution Experiences

Discover Dassault Systèmes® Life Sciences industry solutions driving performance optimization in your biopharma manufacturing facility.

Get Started